Navigate Fool.com
Will AMPE beat
the market?

Ampio Pharmaceuticals, Inc. (NYSEMKT: AMPE)

Community Rating: 1 Star: Ominous

6.27 -0.07 (-1.10%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.34
Previous Close $6.34
Daily Range $6.16 - $6.36
52-Week Range $5.06 - $10.86
Market Cap $325.5M
P/E Ratio -8.45
Dividend (Yield) $0.00 (0.0%)
Volume 561,426
Average Daily Volume 679,890
Current FY EPS -$0.90

How do you think AMPE
will perform against the market?

Top AMPE Bull/Bear Pitches


th3k33p3r24 (0)
Submitted September 20, 2011

I like AMPE for the following reasons:<br />1.&nbsp;&nbsp;&nbsp;Benefit from lack of venture capital:<br />a.&nbsp;&nbsp;&nbsp;Unlike most biotechs and small pharma companies, AMPE has reached an adva … More

1 Replies Reply Report this Post

zzlangerhans (< 20)
Submitted March 14, 2013

You BS about your pipeline Your calls are full of lies You're always telling us 'bout breakthroughs And your stock will reach new highs You say Zertane passed phase III trials But the FDA says no This … More

2 Replies Reply Report this Post

News & Commentary

5 of Last Week's Biggest Winners

These five stocks posted double-digit percentage gains.

3 Horrendous Health-Care Stocks This Week

February's over -- and investors of these horrendous health-care stocks of the week just might be saying "good riddance." Here's why.

Today's Top Biotech Stories: Ampio Pharmaceuticals, Auxilium Pharmaceuticals, Bayer, and Medivation

Today's top stories in healthcare and biotech.

Today's Biggest Biotech Stories: Alexion, Salix, and Ampio

Alexion Pharmaceuticals, Salix Pharmaceuticals, and Ampio Pharmaceuticals could all make health-care headlines this morning.

Ampio Pharmaceuticals Starts Final Study for Osteoarthritis Treatment

Ampio Pharmaceuticals Starts Final Study for Osteoarthritis Treatment.

Ampio Pharmaceuticals: 3 Things to Know Before 2014

What three factors will impact Ampio the most in 2014, and how will other companies, such as Roche, Novartis, and Regeneron, be affected?

Dendreon, Zogenix, and Ampio Pharmaceuticals Could Be Big Movers Today

Keep an eye on Dendreon, Zogenix, and Ampio -- they could make big moves during today's trading.

Why Ampio Pharmaceuticals, Inc. Shares Jumped

Investors want Ampio to show them the money, and Ampio happily obliges!

Healthcare Stocks Narrowly Mixed in Late Trade; Ampio Pharma Jumps 12% After $25-Mln Private Placeme

Healthcare Stocks Narrowly Mixed in Late Trade; Ampio Pharma Jumps 12% After $25-Mln Private Placement

Sector Update: Healthcare

See More AMPE News...





Ampio Pharmaceuticals, Inc. (AMPE) Description

Ampio Pharmaceuticals Inc. is engaged in developing innovative proprietary pharmaceutical drugs and diagnostic products to identify treat and prevent a broad range of human diseases including metabolic disorders cancer etc. Website: http://www.ampiopharma.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks